Lexicon Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Lexicon Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $3.72. The average 1-year stock price forecast is 67.19% higher than the current stock price, while the lowest is $1.50 (-32.58%) and the highest is $6.00 (+169.66%).

Price Target: $3.72 (+67.19%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.50	$3.72	$3.10	$6.00
Change	-32.58%	+67.19%	+39.33%	+169.66%

Analyst Ratings

The average analyst rating for Lexicon Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	0	0	0
Hold	2	2	2	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $2.3 → $3.1	Strong Buy	Maintains	$2.3 → $3.1	+39.33%	May 11, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+169.66%	Mar 23, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $2.1 → $2.3	Strong Buy	Maintains	$2.1 → $2.3	+3.37%	Mar 10, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $4 → $6	Strong Buy	Maintains	$4 → $6	+169.66%	Mar 5, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $4	Strong Buy	Reiterates	$4	+79.78%	Sep 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

34.67M

from 49.80M

-30.39%

from 49.80M

Revenue Next Year

19.99M

from 34.67M

-42.35%

from 34.67M

EPS This Year

-0.18

from -0.14

EPS Next Year

-0.22

from -0.18

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	298.00K	139.00K	1.20M	31.08M	49.80M	34.67M	19.99M
Revenue Growth	-98.76%	-53.36%	766.19%	2,481.48%	60.24%	-30.39%	-42.35%
EPS	-0.60	-0.62	-0.80	-0.63	-0.14	-0.18	-0.22
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	37.2M	58.5M
Avg	34.7M	20.0M
Low	30.5M	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-25.3%	68.7%
Avg	-30.4%	-42.3%
Low	-38.8%	-

EPS Forecast

EPS	2026	2027
High	-0.16	-0.15
Avg	-0.18	-0.22
Low	-0.20	-0.27

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.